Efficacy and safety of fosravuconazole for the treatment of onychomycosis: A multicenter, retrospective study
Not Applicable
- Conditions
- Onychomycosis
- Registration Number
- JPRN-UMIN000045924
- Lead Sponsor
- Sato Pharmaceutical Co.,Ltd
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 350
Inclusion Criteria
Not provided
Exclusion Criteria
1) Patients with significant nail thickening, deformity, or discoloration due to diseases such as palmoplantar pustulosis of the nails, psoriasis vulgaris, lichen planus of the nails, pachyonychia, tumor under the nails, onychogryphosis, etc. 2) Patients who have refused to provide medical information for this study
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method